Germany’s dependence on China rises for batteries, solar panels and antibiotics
New study finds growing German reliance on Chinese suppliers for lithium‑ion batteries, solar panels and antibiotics, raising supply‑security concerns. (152 characters)
Strong opening: study summary
A new analysis by the Friedrich Naumann Foundation for Freedom says Germany’s dependence on China for strategic goods has grown across several sectors, including lithium‑ion batteries, solar panels and antibiotics. The study, based on preliminary data from the German Federal Statistical Office, finds direct imports from China rose markedly in weight and value in the last year. (nampa.org)
Battery imports concentrated in China
The research reports that roughly two‑thirds of Germany’s direct imports of lithium‑ion batteries by weight came from China last year, up from about half two years earlier. That sharp shift highlights how the electric vehicle and energy storage supply chain remains closely tied to Chinese manufacturing and processing capacity. (nampa.org)
China’s dominance in battery components and cell production has been the product of years of upstream investment and integrated supply chains, analysts say. That concentration makes Germany exposed to production slowdowns, export controls or political friction that could disrupt access to batteries and related technologies. (uk.marketscreener.com)
Solar panels and antibiotics show steep gains
The foundation’s analysis also records an increase in China’s share of Germany’s solar panel imports, to about 92–93 percent of total import weight — up from roughly 89 percent previously. At the same time, the share of antibiotics supplied directly from China rose from around 65 percent to roughly 73 percent. These changes suggest reliance is spreading beyond energy transition technologies into medical and pharmaceutical inputs. (nampa.org)
Observers note that even where the percentage share of a supplier falls, the monetary value of imports can rise, underlining how price movements and product mix affect exposure in different ways. The study flags both the scale of Chinese market share and the financial importance of those imports to Germany’s economy. (uk.marketscreener.com)
Critical metals and rare earths concentrated in Chinese supply chains
The report finds rising Chinese shares for metals such as magnesium, gallium and germanium, and it highlights that China remains the near‑exclusive supplier of key rare earth elements used in permanent magnets for electric motors. That near‑monopoly in certain processed rare earths and refined inputs amplifies geopolitical leverage over industries dependent on high‑performance magnets and other components. (nampa.org)
Although the share of China in some categories of rare earth imports has reportedly fallen, the overall value of those imports has increased, the study says — a trend that reflects broader global demand for technology metals and the cost of refined material. (nampa.org)
Research scope and methodological caveats
The Friedrich Naumann Foundation stresses that its analysis covers direct imports from China and does not account for indirect shipments routed through third countries that contain Chinese‑origin components. This limitation means the study may underestimate the true extent of Chinese content embedded in global value chains feeding into Germany. (nampa.org)
The foundation’s author, Frederic Spohr, who heads the organisation’s offices in Asia, warned that increasing dependence in sensitive areas weakens diversification efforts and heightens vulnerability to supply shocks. He contrasted the findings with Berlin’s 2023 China strategy, which aimed to reduce economic dependence on a single supplier. (uk.marketscreener.com)
Policy implications and industry reaction
The report comes amid ongoing policy debates in Berlin and Brussels over “de‑risking” versus decoupling, and how to balance access to China’s market with steps to strengthen European supply security. German industry leaders accompanying official delegations have underscored the pragmatic need for access to Chinese markets and inputs while also calling for measures that boost resilience. (uk.finance.yahoo.com)
For policymakers, the findings add urgency to efforts to diversify suppliers, scale domestic and allied processing capacity, and target investments in raw‑material processing and battery manufacturing. At the same time, businesses warn that rapid onshoring or punitive trade measures could raise costs and complicate trade relations with a major trading partner. (uk.marketscreener.com)
High‑level visit as debate intensifies
The study’s release coincides with a week‑long visit to China by Germany’s economy minister, Katherina Reiche, scheduled from May 26 to May 29, 2026, during which she is leading a business delegation that includes executives from major firms. The timing has focused attention on how bilateral talks will address raw‑material access, industrial cooperation and competition policy. (uk.finance.yahoo.com)
German officials have said the government intends to push for fair competition and greater supply‑chain resilience in discussions with Chinese counterparts, while industry participants aim to secure commercial partnerships and investment ties on the ground. The trip underscores the tension between strategic caution and the economic imperative of maintaining strong trade links. (uk.finance.yahoo.com)
Germany’s dependence on China for strategic batteries, solar modules and antibiotics has increased despite an official 2023 strategy to lower exposure, the foundation’s analysis shows. The findings, based on preliminary federal statistics and public‑sector data, underscore the challenge Berlin faces in reconciling economic interests with supply‑security priorities. (nampa.org)
Policymakers in Germany and at EU level now face choices about investment, regulation and international coordination to reduce single‑supplier risks without severing vital commercial ties. The debate is likely to intensify as governments and companies plan for the energy transition, industrial competition and future public‑health resilience.